The treatment of experimental peritonitis with intraperitoneal betadine solution.
D000042:Absorption; D000818:Animals; D002512:Cephalothin / Q000627:therapeutic use; D004195:Disease Models, Animal; D004927:Escherichia coli Infections / Q000150:complications; D007274:Injections, Intraperitoneal; D007455:Iodine / Q000378:metabolism; D007612:Kanamycin / Q000627:therapeutic use; D010538:Peritonitis / Q000188:drug therapy* / Q000209:etiology; D011205:Povidone / Q000627:therapeutic use*; D011206:Povidone-Iodine / Q000008:administration & dosage / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D013960:Thyroid Function Tests; D000267:Tissue Adhesions / Q000139:chemically induced
D007612:Kanamycin; D011206:Povidone-Iodine; D007455:Iodine; D011205:Povidone; D002512:Cephalothin